Investor Inquiries

FAQ

Please check this FAQ before making your inquiry.

• Can you briefly describe the state of Sumitomo Pharma's finances?

  ボタン

  We proactively engage in IR activities to ensure that our shareholders and investors fully understand how our business is managed. Information regarding the state of our finances will be shared through investor presentations and various materials, as appropriate; please refer to:
  "Investor Relations"

• When will Sumitomo Pharma announce its financial results?

  ボタン

  The schedule for Sumitomo Pharma’s financial results announcements can be found on the IR Calendar page. Please refer to:
  "IR Calendar"

• When is the annual shareholders' meeting?

  ボタン

  It is held in June every year. For details regarding the meeting, please refer to the notice which will be sent to our shareholders prior to the meeting.

• What is Sumitomo Pharma’s views on future dividends?

  ボタン

  Driven by revenue growth in North America and profit recorded from the partial transfer of the Asian business, Sumitomo Pharma's performance for FY2025 improved significantly, with core operating profit and net profit attributable to owners of the parent reaching 105.9 billion JPY and 106.9 billion JPY, respectively. Meanwhile, in pursuit of the growth strategy outlined in “Boost 2028” announced in March 2026, the Company raised funds through a public offering and other means in April 2026. The proceeds will be applied preferentially to accelerating investments centered on research and development and to restoring fiscal health. Accordingly, the Company will suspend year-end dividends for FY2025, as initially expected for the term. The Company now expects to record a core operating profit of 91.0 billion JPY for FY2026, assuming receipt of sales milestone payment from ORGOVYX®. Given the uncertain operating environment, including U.S. pricing policies, tariff measures, and rising costs associated with geopolitical conflicts, the Company has not established a forecast for interim and year-end dividends for FY2026, and it will be determined based on future performance trends and other relevant factors. The Company sincerely appreciate the kind understanding and continued support of our shareholders.

• When is the starting date of dividend payment?

  ボタン

  The term-end dividend is decided on March 31 each year, and its payment starts on the next business day following the annual shareholders' meeting.
  The interim dividend is decided on September 30 each year, and its payment starts on the first business day of December.

• How can I check the number of issued shares and the distribution of shareholders?

  ボタン

  We present this information as part of our biannual financial results announcement.

• Who should I ask if I have a question about procedural formalities, for example in relation to share transfers?

  ボタン

  Procedures concerning our share is handled by the Stock Transfer Agency Department of our registrar, Sumitomo Mitsui Trust Bank, Limited. Please contact them at the number given below.

  Tel.: +81-120-782-031
  Opening hours: 09:00–17:00 on weekdays (JST, excluding weekends, public holidays, and December 31st through to January 3rd)

• Who should I contact if I want to give notice in relation to or if I want information on my holding?

  ボタン

  If you have opened an account with a brokerage firm, please contact your brokerage firm. For shareholders who have not transferred their holdings to Japan Securities Depository Centre, Inc. (JASDEC) prior to the introduction of the Electronic Share Certificate System, we have opened the so-called “special account” with our registrar, Sumitomo Mitsui Trust Bank, Limited. Please contact them at the number given below if you wish notify address change etc. or if you wish to inquire in relation to your special account.

  Tel.: +81-120-782-031
  Opening hours: 09:00–17:00 on weekdays (JST, excluding weekends, public holidays, and December 31st through to January 3rd)

• I have fractional holding of less than one unit of your shares. How can I sell my fractional holding, or buy additional shares to make up a full unit?

  ボタン

  If your fractional holding is held in an account at a brokerage firm, please ask your brokerage firm about the procedure to be followed.
  If you have a special account (see the Q&A above), please ask our registrar, Sumitomo Mitsui Trust Bank, Limited about the procedure to be followed.

  Tel.: +81-120-782-031
  Opening hours: 09:00–17:00 on weekdays (JST, excluding weekends, public holidays, and December 31st through to January 3rd)

• Do you have any shareholder incentive program?

  ボタン

  No shareholder incentive program is currently taking place.

• How can I view your key historical financial data?

  ボタン

  Please refer to the IR materials and Integrated Reports posted here:
  "IR Library"

• Where can I find the materials relating to your financial results?

  ボタン

  Please refer to the IR materials posted here:
  "IR Library"

• Can I view the financial results presentation etc. online?

  ボタン

  Recordings of our financial results presentation etc. are posted on our website and remain available for viewing for about a year. Please refer to:
  "Presentation/Webcast".

Inquiries about Our Share

• Inquiry Form

Inquiries about Research and Development

• Inquiry Form

Other Inquiries